Sunday, September 25, 2005

Genmab Announces Positive Interim Results in (Herpes) Phase I/II HuMax(R)-CD20 CLL Study


Genmab Announces Positive Interim Results in Phase I/II HuMax(R)-CD20 CLL Study
PR Newswire via Yahoo! - potentially related to HuMax-CD20: hepatic cytolysis, herpes zoster, neutropenia (2 patients) and one death from

Herpes Zoster and Postherpetic Neuralgia: Prevention and Management
American Family Physician - Herpes Zoster and Postherpetic Neuralgia: Prevention and Management ANNE L. MOUNSEY, M.D., LEAH G. MATTHEW, M.D., and DAVID C. SLAWSON, M.D. appearance and the dermatomal distribution of herpes zoster lesions usually enable a clinical diagnosis

Vaccine prevents shingles
News Leader - until the rash develops.Doctors refer to shingles as herpes zoster. The viruses that cause mouth fever blisters Those are herpes simplex I and herpes simplex II. Herpes viruses are

FDA OKs Merck combination vaccine
ABCNEWS.com - can also recur in later life as shingles, also known as herpes zoster, a painful and sometimes fatal inflammation

FDA approves combined child vaccine
Washington Times - can also recur in later life as shingles, also known as herpes zoster, a painful and sometimes fatal inflammation

Method and composition for the treatment of shingles and related afflictions
PharmCast - A method and composition for treating herpes zoster varicella and related afflictions is provided to provide a method for treating herpes zoster varicella and related afflictions

Herpes